News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Job Trends
GlaxoSmithKline (JOBS) May Shed 6% of R&D Staff to Save Costs
September 30, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON, Sept 30 (Reuters) - GlaxoSmithKline said on Tuesday it was planning to cut up to 850 research and development jobs in Britain and the United States, in a bid to improve productivity.
Twitter
LinkedIn
Facebook
Email
Print
Job creations
People
Europe
GlaxoSmithKline
MORE ON THIS TOPIC
Europe
AstraZeneca Suspends $270M UK Commitment Months After Scrapping Vaccine Facility
September 15, 2025
·
2 min read
·
Tristan Manalac
Layoff Tracker
Merck To Cut 125 Employees as It Ends UK R&D Work
September 12, 2025
·
198 min read
·
BioSpace Editorial Staff
Job Trends
Hiring Outlook: Fewer Job Openings, High Competition Await Biopharma Job Seekers
September 11, 2025
·
4 min read
·
Angela Gabriel
Layoffs
Novo’s Headcount Rose 81% in Five Years as Revenue Climbed
September 10, 2025
·
1 min read
·
Annalee Armstrong
